scholarly journals Cancer incidence and mortality trends in France over 1990–2018 for solid tumors: the sex gap is narrowing

BMC Cancer ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
G. Defossez ◽  
Z. Uhry ◽  
P. Delafosse ◽  
E. Dantony ◽  
T. d’Almeida ◽  
...  

Abstract Objective To analyze trends in cancer incidence and mortality (France, 1990–2018), with a focus on men-women disparities. Methods Incidence data stemmed from cancer registries (FRANCIM) and mortality data from national statistics (CépiDc). Incidence and mortality rates were modelled using bidimensional penalized splines of age and year (at diagnosis and at death, respectively). Trends in age-standardized rates were summarized by the average annual percent changes (AAPC) for all-cancers combined, 19 solid tumors, and 8 subsites. Sex gaps were indicated using male-to-female rate ratios (relative difference) and male-to-female rate differences (absolute difference) in 1990 and 2018, for incidence and mortality, respectively. Results For all-cancers, the sex gap narrowed over 1990–2018 in incidence (1.6 to 1.2) and mortality (2.3 to 1.7). The largest decreases of the male-to-female incidence rate ratio were for cancers of the lung (9.5 to 2.2), lip - oral cavity - pharynx (10.9 to 3.1), esophagus (12.6 to 4.5) and larynx (17.1 to 7.1). Mixed trends emerged in lung and oesophageal cancers, probably explained by differing risk factors for the two main histological subtypes. Sex incidence gaps narrowed due to increasing trends in men and women for skin melanoma (0.7 to 1, due to initially higher rates in women), cancers of the liver (7.4 to 4.4) and pancreas (2.0 to 1.4). Sex incidence gaps narrowed for colon-rectum (1.7 to 1.4), urinary bladder (6.9 to 6.1) and stomach (2.7 to 2.4) driven by decreasing trends among men. Other cancers showed similar increasing incidence trends in both sexes leading to stable sex gaps: thyroid gland (0.3 to 0.3), kidney (2.2 to 2.4) and central nervous system (1.4 to 1.5). Conclusion In France in 2018, while men still had higher risks of developing or dying from most cancers, the sex gap was narrowing. Efforts should focus on avoiding risk factors (e.g., smoking) and developing etiological studies to understand currently unexplained increasing trends.

2014 ◽  
Vol 62 (2) ◽  
pp. 95-108 ◽  
Author(s):  
F. Binder-Foucard ◽  
N. Bossard ◽  
P. Delafosse ◽  
A. Belot ◽  
A.-S. Woronoff ◽  
...  

2020 ◽  
Vol 49 (4) ◽  
pp. 1294-1306 ◽  
Author(s):  
Zoé Uhry ◽  
Edouard Chatignoux ◽  
Emmanuelle Dantony ◽  
Marc Colonna ◽  
Laurent Roche ◽  
...  

Abstract Background Cancer-incidence and mortality-trend analyses require appropriate statistical modelling. In countries without a nationwide cancer registry, an additional issue is estimating national incidence from local-registry data. The objectives of this study were to (i) promote the use of multidimensional penalized splines (MPS) for trend analyses; (ii) estimate the national cancer-incidence trends, using MPS, from only local-registry data; and (iii) propose a validation process of these estimates. Methods We used an MPS model of age and year for trend analyses in France over 1990–2015 with a projection up to 2018. Validation was performed for 22 cancer sites and relied essentially on comparison with reference estimates that used the incidence/health-care ratio over the period 2011–2015. Alternative estimates that used the incidence/mortality ratio were also used to validate the trends. Results In the validation assessment, the relative differences of the incidence estimates (2011–2015) with the reference estimates were <5% except for testis cancer in men and < 7% except for larynx cancer in women. Trends could be correctly derived since 1990 despite incomplete histories in some registries. The proposed method was applied to estimate the incidence and mortality trends of female lung cancer and prostate cancer in France. Conclusions The validation process confirmed the validity of the national French estimates; it may be applied in other countries to help in choosing the most appropriate national estimation method according to country-specific contexts. MPS form a powerful statistical tool for trend analyses; they allow trends to vary smoothly with age and are suitable for modelling simple as well as complex trends thanks to penalization. Detailed trend analyses of lung and prostate cancers illustrated the suitability of MPS and the epidemiological interest of such analyses.


2012 ◽  
pp. 256-266 ◽  
Author(s):  
Maria Clara Yepez ◽  
Luis Eduardo Bravo ◽  
Arsenio Hidalgo Troya ◽  
Daniel Marcelo Jurado ◽  
Luisa Mercedes Bravo

Introduction: In Colombia, information on cancer morbidity at the population level is limited. Incidence es­timates for most regions are based on mortality data. To improve the validity of these estimates, it is necessary that other population-based cancer registries, as well as Cali, provide cancer risk information. Objective: To describe the incidence and cancer mortality in the municipality of Pasto within the 1998-2007 period. Methodology: The study population belongs to rural and urban areas of the municipality of Pasto. Collection, processing, and systematization of the data were performed according to internationally standardized parame­ters for population-based cancer registries. The cancer incidence and mortality rates were calculated by gender, age, and tumor site. Results: During the 1998-2007 period 4,986 new cases of cancer were recorded of which 57.7% were in female. 2,503 deaths were presented, 52% in female. Neoplasm-associated infections are the leading cause of cancer morbidity in Pasto: stomach cancer in males and cervical cancer in females. Discussion: Cancer in general is a major health problem for the population of the municipality of Pasto. The overall behavior of the increasing incidence and cancer mortality in relation to other causes of death show the need to implement and strengthen prevention and promotion programs, focusing especially on tumors that produce greater morbidity and mortality in the population.


2018 ◽  
Author(s):  
Fábia Cheyenne Gomes de Morais Fernandes ◽  
Dyego Leandro Bezerra de Souza ◽  
Maria Paula Curado ◽  
Isabelle Ribeiro Barbosa

This study analyzed trends in thyroid cancer incidence and mortality in countries of Latin America. Ecological study of time series, with incidence data extracted from the International Agency for Research on Cancer (IARC), in the 1990-2012 period and mortality data obtained from 16 countries of the World Health Organization (WHO), in the 1995-2013 period. The trend of incidence rate was analyzed by the Joinpoint regression. The average annual percentage change (AAPC) and the 95% confidence interval (CI 95%) were calculated for incidence and mortality. The average rate of thyroid cancer incidence was higher in Quito (Ecuador) between the ages of 40 to 59 years old, 42.2 new cases per 100,000 inhabitants, as well as mortality 4.8 deaths per 100,000 women inhabitants above 60 years old. There was an increase in thyroid cancer incidence trends in women, for all age groups, in Cali, Costa Rica and Quito and men in Costa Rica; there was stability above the age of 60 years old in Cali, Goiania, Quito and Valdivia in men, as well as women in Goiania and Valdivia. There was a trend of increasing mortality for females in three countries: Ecuador (AAPC= 3,28 CI 95% 1,36;5,24), Guatemala (AAPC= 6,14 CI 95% 2,81;9,58) and Mexico (AAPC= 0,67 CI 95% 0,16;1,18). Thyroid cancer in Latin America showed a high incidence, with increased incidence in women. Stability in mortality was observed for most countries of Latin America.


2004 ◽  
Vol 43 (05) ◽  
pp. 493-498 ◽  
Author(s):  
A. Daugs ◽  
M. Meyer ◽  
M. Radespiel-Tröger

Summary Objectives: Cancer epidemiologists are often asked by members of the interested public about possible associations between suspected carcinogens and apparently increased small-area cancer incidence rates. Frequently, no systematic incidence differences can be demonstrated. Nevertheless, it is necessary to address public concerns about suspected cancer clusters. To facilitate explanations about the large random variation of small-area tumor incidence, we implemented a software simulation tool in R. Methods: Under the assumption of no cancer causes other than chance, the tool simulates a small village population with an average number of five inhabitants per house and allows graphical visualisation of ten streets with 100 houses. Published age-specific incidence and mortality data are used for event sampling based on the binomial distribution. Program parameters include sample size, age distribution, cancer incidence, and mortality rates. Results: On average, 22 percent (2.2/10) of all houses per street have been inhabited by at least one cancer patient during the last five years in our simulated small village. A situation where all (10) houses in a street have been inhabited by at least one cancer patient during the last five years appears to be very rare (less than one in a million streets). Conclusions: Our software tool can be used effectively for numerical and graphical visualisation of small-area tumour incidence and prevalence rates due to chance alone. The explanation of basic epidemiological concepts to members of the public can help to increase public motivation and support for population-based cancer registration. Our simulation tool can be used to support this goal.


2005 ◽  
Vol 23 (2) ◽  
pp. 301-310 ◽  
Author(s):  
Carolyn C. Gotay

This paper reviews research on the effects of behavioral risk factors on cancer incidence, as well as behavioral interventions for cancer prevention. Risk factors discussed here—tobacco use, diet, physical activity, and obesity/energy balance—are all linked with cancer etiology, and effective behavioral interventions have been developed in all of these areas. The most effective interventions appear to incorporate various components; for example, including individual as well as family activities, and involving multiple community organizations in behavior-changing activities. Behavioral theories have guided the design of these interventions, providing support that certain influences on behavior, such as self-efficacy, problem-solving skills, and social support, are important regardless of the specific behavioral target. As illustrated by the recent lowered lung cancer incidence and mortality rates for men and women, behavior change is possible and effective in cancer prevention. Clinical guidelines have been established for behavioral aspects of treatments for smoking cessation, dietary guideline compliance, physical activity, and obesity reduction, and new tools for dissemination of effective intervention materials will be helpful in increasing their use. Documenting the cost-effectiveness of behavioral interventions, using new technology interventions, and building on translational research to tailor interventions to individuals offer considerable promise for the future.


2020 ◽  
Vol 10 (1) ◽  
pp. 56-63
Author(s):  
S. N. Navruzov ◽  
D. A. Alieva ◽  
E. E. Kulmiev

Objective: epidemiological evaluation of global trends in colorectal cancer and assessment of colon cancer incidence in the Republic of Uzbekistan in 2012–2017.Materials and methods. We used GLOBOCAN data to analyze the situation with colorectal cancer worldwide. We also assessed the incidence of colon cancer, trends, and mean age of patients (by years) registered in the Republic of Uzbekistan. This article emphasizes the need for epidemiological studies of colorectal cancer in Uzbekistan.Results. World trends in colorectal cancer incidence and mortality indicate that these parameters vary across different regions and depend on the economic situation. There are also some sex differences: men are more likely to develop colorectal cancer than women (male to female ratio 1.25:1.0). The number of patient died of colorectal cancer is growing; the male to female ratio is 1.22:1.0.Conclusions. Our assessment of epidemiological situation of colon cancer in the Republic of Uzbekistan demonstrated that its incidence tends to increase, which necessitates further research evaluating regional differences and risk factors for colorectal cancer.


Sign in / Sign up

Export Citation Format

Share Document